Venetoclax is a BCL2 homology domain 3 (BH3) mimetic that blocks the anti-apoptotic B-cell lymphoma-2 (Bcl-2) protein leading to programmed cell death of chronic lymphocytic leukemia (CLL) cells. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.